A detailed history of Townsquare Capital LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Townsquare Capital LLC holds 5,208 shares of EW stock, worth $385,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,208
Previous 4,322 20.5%
Holding current value
$385,027
Previous $399,000 14.04%
% of portfolio
0.0%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$59.7 - $93.78 $52,894 - $83,089
886 Added 20.5%
5,208 $343,000
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $76,713 - $85,822
910 Added 26.67%
4,322 $399,000
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $17,772 - $23,412
245 Added 7.74%
3,412 $326,000
Q4 2023

Feb 15, 2024

SELL
$61.71 - $77.76 $308,858 - $389,188
-5,005 Reduced 61.25%
3,167 $241,000
Q3 2023

Nov 15, 2023

BUY
$69.28 - $93.38 $50,089 - $67,513
723 Added 9.71%
8,172 $566,000
Q2 2023

Nov 13, 2023

SELL
$81.41 - $94.33 $87,108 - $100,933
-1,070 Reduced 12.56%
7,449 $702,000
Q1 2023

May 11, 2023

BUY
$74.26 - $84.51 $389,122 - $442,832
5,240 Added 159.8%
8,519 $704,000
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $30,735 - $39,348
450 Added 15.91%
3,279 $244,000
Q1 2022

Apr 28, 2022

SELL
$101.96 - $128.34 $1,529 - $1,925
-15 Reduced 0.53%
2,829 $333,000
Q3 2020

Dec 01, 2020

BUY
$67.19 - $87.44 $191,088 - $248,679
2,844 New
2,844 $224,000
Q1 2020

May 18, 2020

SELL
$52.41 - $81.0 $58,332 - $90,153
-1,113 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $3,508 - $4,299
-57 Reduced 4.87%
1,113 $262,000
Q2 2019

Aug 15, 2019

SELL
$55.74 - $64.41 $8,416 - $9,725
-151 Reduced 11.43%
1,170 $251,000
Q1 2019

May 15, 2019

BUY
$47.89 - $64.05 $5,507 - $7,365
115 Added 9.54%
1,321 $253,000
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $55,970 - $68,669
1,206 New
1,206 $205,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Townsquare Capital LLC Portfolio

Follow Townsquare Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.